BAC Water 10mL
Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilised peptides.

SKU: PEP-035-10MG
A synthetic cyclic heptapeptide melanocortin receptor agonist (bremelanotide), supplied as a 10mg lyophilised vial. Research use only. Preorder — ships with the first batch.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Preorder: dispatched once the next batch arrives, tracked with Australia Post
Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilised peptides.
A stabilised analogue of growth-hormone-releasing hormone (GHRH).
A synthetic cyclic heptapeptide melanocortin receptor agonist (bremelanotide), supplied as a 10mg lyophilised vial.
It is studied for melanocortin MC3R and MC4R pharmacology and central signalling pathways.
This product is currently available to preorder and ships once the first batch has been produced and tested. Strictly for in-vitro laboratory research only.
A synthetic cyclic heptapeptide melanocortin receptor agonist (bremelanotide), supplied as a 10mg lyophilised vial. It is studied for melanocortin MC3R and MC4R pharmacology and central signalling pathways. All use is strictly for in-vitro laboratory research only.
This product is a preorder. It is not held in stock yet and ships with the first batch; you will be emailed when your order is dispatched.
Batch testing documentation is published for each batch once it has been produced and tested. Contact us before ordering if you need it first.
Store lyophilised product at −20°C, protected from light and moisture, and avoid repeated freeze-thaw cycles.
No. PT-141 is supplied for in-vitro laboratory research only and is not approved for human consumption or therapeutic use. Scheduling attaches to the substance and changes over time; verify the current status against the TGA Poisons Standard.
PT-141 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
Recent peer-reviewed studies from PubMed related to PT-141. Provided for research context — not medical advice.
Bremelanotide
2012
PMID: 34436837
Bremelanotide: First Approval
Dhillon S, Keam SJ · Drugs · 2019
PMID: 31429064
Bremelanotide
2006
PMID: 31369224
Bremelanotide for Treatment of Female Hypoactive Sexual Desire
Edinoff AN, Sanders NM, Lewis KB, et al. · Neurology international · 2022
PMID: 35076581
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.